FDA Inspection 839238 — AstraZeneca Dunkerque Production (AZDP)
The FDA completed an inspection of AstraZeneca Dunkerque Production (AZDP) on May 17, 2013 in Dordogne. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 17, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dordogne (France)